Bioprocess Automation: Truth Or Illusion?
Source: Cytiva
iBio COO Randy Maddux, Kyowa Kirin, EVP of Operations and Supply Chain Paul Testa, and Sutro Biopharma VP of Manufacturing and Plant Operations Devendra Luhar joined Matt Pillar, Chief Editor of Bioprocess Online for a spirited, interactive discussion on aversions to biopharma manufacturing automation, the technology, cost, and implementation challenges it presents, and why you should commit to it anyway. Actionable insights include the stepwise, cost-conscious approaches the panelists are taking to improving quality control and data integrity through automation.
VIEW THE WEBINAR!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Drug Discovery Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
Cytiva
This website uses cookies to ensure you get the best experience on our website. Learn more